Cargando…
Management strategies and cost effectiveness in the prevention of cervical cancer
This paper introduces the burden of cervical cancer and the primary and secondary preventative interventions currently available, and provides an overview of the bivalent and quadrivalent human papillomavirus (HPV) vaccines. A brief account of the virology and the clinical efficacy of both is given....
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169989/ https://www.ncbi.nlm.nih.gov/pubmed/21935303 |
_version_ | 1782211563065704448 |
---|---|
author | Prasad, Smita R |
author_facet | Prasad, Smita R |
author_sort | Prasad, Smita R |
collection | PubMed |
description | This paper introduces the burden of cervical cancer and the primary and secondary preventative interventions currently available, and provides an overview of the bivalent and quadrivalent human papillomavirus (HPV) vaccines. A brief account of the virology and the clinical efficacy of both is given. Examinations of the two main types of cost analyses, cost-effective and cost-benefit, as well as examples, are presented in addition to the possible impact these analyses and further economic models will have on budget and policy making decisions. In general, most cost analyses provide support for the implementation of primary prevention strategies, HPV immunization, in conjunction with cervical cancer screening programs. Vaccination against HPV, therefore, is a cost-effective cervical cancer prevention mechanism. |
format | Online Article Text |
id | pubmed-3169989 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-31699892011-09-20 Management strategies and cost effectiveness in the prevention of cervical cancer Prasad, Smita R Clinicoecon Outcomes Res Review This paper introduces the burden of cervical cancer and the primary and secondary preventative interventions currently available, and provides an overview of the bivalent and quadrivalent human papillomavirus (HPV) vaccines. A brief account of the virology and the clinical efficacy of both is given. Examinations of the two main types of cost analyses, cost-effective and cost-benefit, as well as examples, are presented in addition to the possible impact these analyses and further economic models will have on budget and policy making decisions. In general, most cost analyses provide support for the implementation of primary prevention strategies, HPV immunization, in conjunction with cervical cancer screening programs. Vaccination against HPV, therefore, is a cost-effective cervical cancer prevention mechanism. Dove Medical Press 2009-06-05 /pmc/articles/PMC3169989/ /pubmed/21935303 Text en © 2009 Prasad, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Review Prasad, Smita R Management strategies and cost effectiveness in the prevention of cervical cancer |
title | Management strategies and cost effectiveness in the prevention of cervical cancer |
title_full | Management strategies and cost effectiveness in the prevention of cervical cancer |
title_fullStr | Management strategies and cost effectiveness in the prevention of cervical cancer |
title_full_unstemmed | Management strategies and cost effectiveness in the prevention of cervical cancer |
title_short | Management strategies and cost effectiveness in the prevention of cervical cancer |
title_sort | management strategies and cost effectiveness in the prevention of cervical cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169989/ https://www.ncbi.nlm.nih.gov/pubmed/21935303 |
work_keys_str_mv | AT prasadsmitar managementstrategiesandcosteffectivenessinthepreventionofcervicalcancer |